BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 33439370)

  • 1. Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?
    Abu-Amna M; Salti T; Khoury M; Cohen I; Bar-Sela G
    Curr Treat Options Oncol; 2021 Jan; 22(2):16. PubMed ID: 33439370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology.
    Turgeman I; Bar-Sela G
    Expert Opin Investig Drugs; 2019 Mar; 28(3):285-296. PubMed ID: 30572744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Use of State Medical Cannabis Legislation as a Proxy for Medical Cannabis Use Among Patients Receiving Chemotherapy.
    Gressler LE; Baltz AP; Costantino RC; Slejko JF; Onukwugha E
    Curr Treat Options Oncol; 2020 Nov; 22(1):1. PubMed ID: 33215230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cannabinoids in cancer patients: A Society of Gynecologic Oncology (SGO) clinical practice statement.
    Whitcomb B; Lutman C; Pearl M; Medlin E; Prendergast E; Robison K; Burke W
    Gynecol Oncol; 2020 May; 157(2):307-311. PubMed ID: 31932107
    [No Abstract]   [Full Text] [Related]  

  • 5. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should Oncologists Recommend Cannabis?
    Abrams DI
    Curr Treat Options Oncol; 2019 Jun; 20(7):59. PubMed ID: 31161270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
    Krcevski-Skvarc N; Wells C; Häuser W
    Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Medical Cannabis in an Oncology Practice.
    Abrams DI
    Oncology (Williston Park); 2016 May; 30(5):397-404. PubMed ID: 27188670
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of Medical Marijuana in Cancer.
    Birdsall SM; Birdsall TC; Tims LA
    Curr Oncol Rep; 2016 Jul; 18(7):40. PubMed ID: 27215434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient Counseling Guidelines for the Use of Cannabis for the Treatment of Chemotherapy-Induced Nausea/Vomiting and Chronic Pain.
    Makary P; Parmar JR; Mims N; Khanfar NM; Freeman RA
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):216-225. PubMed ID: 31070496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the clinical use of cannabis by oncology patients advisable?
    Bar-Sela G; Avisar A; Batash R; Schaffer M
    Curr Med Chem; 2014 Jun; 21(17):1923-30. PubMed ID: 24606496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.
    Tafelski S; Häuser W; Schäfer M
    Schmerz; 2016 Feb; 30(1):14-24. PubMed ID: 26787227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature.
    Inglet S; Winter B; Yost SE; Entringer S; Lian A; Biksacky M; Pitt RD; Mortensen W
    Ann Pharmacother; 2020 Nov; 54(11):1109-1143. PubMed ID: 32483988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care.
    Abrams DI
    Integr Cancer Ther; 2022; 21():15347354221081772. PubMed ID: 35225051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials.
    Wang L; Hong PJ; May C; Rehman Y; Oparin Y; Hong CJ; Hong BY; AminiLari M; Gallo L; Kaushal A; Craigie S; Couban RJ; Kum E; Shanthanna H; Price I; Upadhye S; Ware MA; Campbell F; Buchbinder R; Agoritsas T; Busse JW
    BMJ; 2021 Sep; 374():n1034. PubMed ID: 34497047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis and cannabinoids in cancer pain management.
    Meng H; Dai T; Hanlon JG; Downar J; Alibhai SMH; Clarke H
    Curr Opin Support Palliat Care; 2020 Jun; 14(2):87-93. PubMed ID: 32332209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled medicinal cannabis and the immunocompromised patient.
    Ruchlemer R; Amit-Kohn M; Raveh D; Hanuš L
    Support Care Cancer; 2015 Mar; 23(3):819-22. PubMed ID: 25216851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical cannabis use in oncology and associated outcomes: A scoping review.
    Valente AC; Lopes LPN; Matheus ME
    J Oncol Pharm Pract; 2024 Jun; 30(4):737-751. PubMed ID: 38477532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis use among adults undergoing cancer treatment.
    Azizoddin DR; Cohn AM; Ulahannan SV; Henson CE; Alexander AC; Moore KN; Holman LL; Boozary LK; Sifat MS; Kendzor DE
    Cancer; 2023 Nov; 129(21):3498-3508. PubMed ID: 37354093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.